Well no scoping study today which means we still have much to look forward too , I still like my chances of doing well with RXL , the gold is there , good things take time, a positive for me was my decision to sell another goldie and buy RXL , the other has plummeted 500%
- Forums
- ASX - By Stock
- RXL
- No Scoping Study No Sp Re-Rate Mungy
RXL
rox resources limited
Add to My Watchlist
0.00%
!
29.0¢

No Scoping Study No Sp Re-Rate Mungy, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $216.4M |
Open | High | Low | Value | Volume |
29.0¢ | 30.0¢ | 28.8¢ | $606.5K | 2.081M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 210884 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 536343 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 235884 | 0.285 |
7 | 339192 | 0.280 |
8 | 441490 | 0.275 |
14 | 410976 | 0.270 |
4 | 267286 | 0.265 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 536343 | 3 |
0.295 | 66112 | 7 |
0.300 | 308294 | 10 |
0.305 | 133050 | 6 |
0.310 | 174467 | 7 |
Last trade - 14.52pm 01/07/2025 (20 minute delay) ? |
Featured News
RXL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online